Global Exosome Therapeutics and Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.
The global Exosome Therapeutics and Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Exosome Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Exosome Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapeutics and Diagnostics sales for 2023 through 2029. With Exosome Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Exosome Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapeutics and Diagnostics.
United States market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Therapeutics and Diagnostics players cover Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.
The global Exosome Therapeutics and Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Exosome Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Exosome Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapeutics and Diagnostics sales for 2023 through 2029. With Exosome Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Exosome Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapeutics and Diagnostics.
United States market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Therapeutics and Diagnostics players cover Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Treatment
- Diagnosis
- Cancer
- Neurological Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Treatment
- Diagnosis
- Cancer
- Neurological Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Evox Therapeutics
- Carmine Therapeutics
- Exopharm
- Aruna Bio
- Capricor Therapeutics
- Mantra Bio
- Adipomics
- ReNeuron
- Aegle Therapeutics
- Sarepta Therapeutics
- Codiak Biosciences
- Exosomics
- Innocan Pharma
- Aethlon Medical
- ExoCoBio
- Organicell
- Puretech
- Versatope
- Vesvigen Therapeutics
- Exosome Plus
- Exosome Diagnostics
- ECHO Biaotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosome Therapeutics and Diagnostics Market Size 2019-2030
2.1.2 Exosome Therapeutics and Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Exosome Therapeutics and Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Exosome Therapeutics and Diagnostics Segment by Type
2.2.1 Treatment
2.2.2 Diagnosis
2.3 Exosome Therapeutics and Diagnostics Market Size by Type
2.3.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Exosome Therapeutics and Diagnostics Segment by Application
2.4.1 Cancer
2.4.2 Neurological Diseases
2.4.3 Others
2.5 Exosome Therapeutics and Diagnostics Market Size by Application
2.5.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
3 EXOSOME THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Exosome Therapeutics and Diagnostics Market Size Market Share by Player
3.1.1 Global Exosome Therapeutics and Diagnostics Revenue by Player (2019-2024)
3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player (2019-2024)
3.2 Global Exosome Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOME THERAPEUTICS AND DIAGNOSTICS BY REGION
4.1 Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
4.2 Global Exosome Therapeutics and Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.4 APAC Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.5 Europe Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.6 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
5.2 Americas Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
5.3 Americas Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
6.2 APAC Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
6.3 APAC Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.2 Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosome Therapeutics and Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOME THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.2 Americas Exosome Therapeutics and Diagnostics Forecast
10.1.3 APAC Exosome Therapeutics and Diagnostics Forecast
10.1.4 Europe Exosome Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast
10.2 Americas Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Market Exosome Therapeutics and Diagnostics Forecast
10.2.2 Canada Market Exosome Therapeutics and Diagnostics Forecast
10.2.3 Mexico Market Exosome Therapeutics and Diagnostics Forecast
10.2.4 Brazil Market Exosome Therapeutics and Diagnostics Forecast
10.3 APAC Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.3.1 China Exosome Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Market Exosome Therapeutics and Diagnostics Forecast
10.3.3 Korea Market Exosome Therapeutics and Diagnostics Forecast
10.3.4 Southeast Asia Market Exosome Therapeutics and Diagnostics Forecast
10.3.5 India Market Exosome Therapeutics and Diagnostics Forecast
10.3.6 Australia Market Exosome Therapeutics and Diagnostics Forecast
10.4 Europe Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Market Exosome Therapeutics and Diagnostics Forecast
10.4.2 France Market Exosome Therapeutics and Diagnostics Forecast
10.4.3 UK Market Exosome Therapeutics and Diagnostics Forecast
10.4.4 Italy Market Exosome Therapeutics and Diagnostics Forecast
10.4.5 Russia Market Exosome Therapeutics and Diagnostics Forecast
10.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Market Exosome Therapeutics and Diagnostics Forecast
10.5.2 South Africa Market Exosome Therapeutics and Diagnostics Forecast
10.5.3 Israel Market Exosome Therapeutics and Diagnostics Forecast
10.5.4 Turkey Market Exosome Therapeutics and Diagnostics Forecast
10.6 Global Exosome Therapeutics and Diagnostics Forecast by Type (2025-2030)
10.7 Global Exosome Therapeutics and Diagnostics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Exosome Therapeutics and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Evox Therapeutics
11.1.1 Evox Therapeutics Company Information
11.1.2 Evox Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Evox Therapeutics Main Business Overview
11.1.5 Evox Therapeutics Latest Developments
11.2 Carmine Therapeutics
11.2.1 Carmine Therapeutics Company Information
11.2.2 Carmine Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Carmine Therapeutics Main Business Overview
11.2.5 Carmine Therapeutics Latest Developments
11.3 Exopharm
11.3.1 Exopharm Company Information
11.3.2 Exopharm Exosome Therapeutics and Diagnostics Product Offered
11.3.3 Exopharm Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Exopharm Main Business Overview
11.3.5 Exopharm Latest Developments
11.4 Aruna Bio
11.4.1 Aruna Bio Company Information
11.4.2 Aruna Bio Exosome Therapeutics and Diagnostics Product Offered
11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aruna Bio Main Business Overview
11.4.5 Aruna Bio Latest Developments
11.5 Capricor Therapeutics
11.5.1 Capricor Therapeutics Company Information
11.5.2 Capricor Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Capricor Therapeutics Main Business Overview
11.5.5 Capricor Therapeutics Latest Developments
11.6 Mantra Bio
11.6.1 Mantra Bio Company Information
11.6.2 Mantra Bio Exosome Therapeutics and Diagnostics Product Offered
11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mantra Bio Main Business Overview
11.6.5 Mantra Bio Latest Developments
11.7 Adipomics
11.7.1 Adipomics Company Information
11.7.2 Adipomics Exosome Therapeutics and Diagnostics Product Offered
11.7.3 Adipomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Adipomics Main Business Overview
11.7.5 Adipomics Latest Developments
11.8 ReNeuron
11.8.1 ReNeuron Company Information
11.8.2 ReNeuron Exosome Therapeutics and Diagnostics Product Offered
11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ReNeuron Main Business Overview
11.8.5 ReNeuron Latest Developments
11.9 Aegle Therapeutics
11.9.1 Aegle Therapeutics Company Information
11.9.2 Aegle Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Aegle Therapeutics Main Business Overview
11.9.5 Aegle Therapeutics Latest Developments
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Information
11.10.2 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sarepta Therapeutics Main Business Overview
11.10.5 Sarepta Therapeutics Latest Developments
11.11 Codiak Biosciences
11.11.1 Codiak Biosciences Company Information
11.11.2 Codiak Biosciences Exosome Therapeutics and Diagnostics Product Offered
11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Codiak Biosciences Main Business Overview
11.11.5 Codiak Biosciences Latest Developments
11.12 Exosomics
11.12.1 Exosomics Company Information
11.12.2 Exosomics Exosome Therapeutics and Diagnostics Product Offered
11.12.3 Exosomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exosomics Main Business Overview
11.12.5 Exosomics Latest Developments
11.13 Innocan Pharma
11.13.1 Innocan Pharma Company Information
11.13.2 Innocan Pharma Exosome Therapeutics and Diagnostics Product Offered
11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Innocan Pharma Main Business Overview
11.13.5 Innocan Pharma Latest Developments
11.14 Aethlon Medical
11.14.1 Aethlon Medical Company Information
11.14.2 Aethlon Medical Exosome Therapeutics and Diagnostics Product Offered
11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Aethlon Medical Main Business Overview
11.14.5 Aethlon Medical Latest Developments
11.15 ExoCoBio
11.15.1 ExoCoBio Company Information
11.15.2 ExoCoBio Exosome Therapeutics and Diagnostics Product Offered
11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ExoCoBio Main Business Overview
11.15.5 ExoCoBio Latest Developments
11.16 Organicell
11.16.1 Organicell Company Information
11.16.2 Organicell Exosome Therapeutics and Diagnostics Product Offered
11.16.3 Organicell Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Organicell Main Business Overview
11.16.5 Organicell Latest Developments
11.17 Puretech
11.17.1 Puretech Company Information
11.17.2 Puretech Exosome Therapeutics and Diagnostics Product Offered
11.17.3 Puretech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Puretech Main Business Overview
11.17.5 Puretech Latest Developments
11.18 Versatope
11.18.1 Versatope Company Information
11.18.2 Versatope Exosome Therapeutics and Diagnostics Product Offered
11.18.3 Versatope Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Versatope Main Business Overview
11.18.5 Versatope Latest Developments
11.19 Vesvigen Therapeutics
11.19.1 Vesvigen Therapeutics Company Information
11.19.2 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Vesvigen Therapeutics Main Business Overview
11.19.5 Vesvigen Therapeutics Latest Developments
11.20 Exosome Plus
11.20.1 Exosome Plus Company Information
11.20.2 Exosome Plus Exosome Therapeutics and Diagnostics Product Offered
11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Exosome Plus Main Business Overview
11.20.5 Exosome Plus Latest Developments
11.21 Exosome Diagnostics
11.21.1 Exosome Diagnostics Company Information
11.21.2 Exosome Diagnostics Exosome Therapeutics and Diagnostics Product Offered
11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Exosome Diagnostics Main Business Overview
11.21.5 Exosome Diagnostics Latest Developments
11.22 ECHO Biaotech
11.22.1 ECHO Biaotech Company Information
11.22.2 ECHO Biaotech Exosome Therapeutics and Diagnostics Product Offered
11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 ECHO Biaotech Main Business Overview
11.22.5 ECHO Biaotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosome Therapeutics and Diagnostics Market Size 2019-2030
2.1.2 Exosome Therapeutics and Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Exosome Therapeutics and Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Exosome Therapeutics and Diagnostics Segment by Type
2.2.1 Treatment
2.2.2 Diagnosis
2.3 Exosome Therapeutics and Diagnostics Market Size by Type
2.3.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Exosome Therapeutics and Diagnostics Segment by Application
2.4.1 Cancer
2.4.2 Neurological Diseases
2.4.3 Others
2.5 Exosome Therapeutics and Diagnostics Market Size by Application
2.5.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
3 EXOSOME THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Exosome Therapeutics and Diagnostics Market Size Market Share by Player
3.1.1 Global Exosome Therapeutics and Diagnostics Revenue by Player (2019-2024)
3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player (2019-2024)
3.2 Global Exosome Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOME THERAPEUTICS AND DIAGNOSTICS BY REGION
4.1 Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
4.2 Global Exosome Therapeutics and Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.4 APAC Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.5 Europe Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.6 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
5.2 Americas Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
5.3 Americas Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
6.2 APAC Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
6.3 APAC Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.2 Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosome Therapeutics and Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOME THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.2 Americas Exosome Therapeutics and Diagnostics Forecast
10.1.3 APAC Exosome Therapeutics and Diagnostics Forecast
10.1.4 Europe Exosome Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast
10.2 Americas Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Market Exosome Therapeutics and Diagnostics Forecast
10.2.2 Canada Market Exosome Therapeutics and Diagnostics Forecast
10.2.3 Mexico Market Exosome Therapeutics and Diagnostics Forecast
10.2.4 Brazil Market Exosome Therapeutics and Diagnostics Forecast
10.3 APAC Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.3.1 China Exosome Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Market Exosome Therapeutics and Diagnostics Forecast
10.3.3 Korea Market Exosome Therapeutics and Diagnostics Forecast
10.3.4 Southeast Asia Market Exosome Therapeutics and Diagnostics Forecast
10.3.5 India Market Exosome Therapeutics and Diagnostics Forecast
10.3.6 Australia Market Exosome Therapeutics and Diagnostics Forecast
10.4 Europe Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Market Exosome Therapeutics and Diagnostics Forecast
10.4.2 France Market Exosome Therapeutics and Diagnostics Forecast
10.4.3 UK Market Exosome Therapeutics and Diagnostics Forecast
10.4.4 Italy Market Exosome Therapeutics and Diagnostics Forecast
10.4.5 Russia Market Exosome Therapeutics and Diagnostics Forecast
10.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Market Exosome Therapeutics and Diagnostics Forecast
10.5.2 South Africa Market Exosome Therapeutics and Diagnostics Forecast
10.5.3 Israel Market Exosome Therapeutics and Diagnostics Forecast
10.5.4 Turkey Market Exosome Therapeutics and Diagnostics Forecast
10.6 Global Exosome Therapeutics and Diagnostics Forecast by Type (2025-2030)
10.7 Global Exosome Therapeutics and Diagnostics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Exosome Therapeutics and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Evox Therapeutics
11.1.1 Evox Therapeutics Company Information
11.1.2 Evox Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Evox Therapeutics Main Business Overview
11.1.5 Evox Therapeutics Latest Developments
11.2 Carmine Therapeutics
11.2.1 Carmine Therapeutics Company Information
11.2.2 Carmine Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Carmine Therapeutics Main Business Overview
11.2.5 Carmine Therapeutics Latest Developments
11.3 Exopharm
11.3.1 Exopharm Company Information
11.3.2 Exopharm Exosome Therapeutics and Diagnostics Product Offered
11.3.3 Exopharm Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Exopharm Main Business Overview
11.3.5 Exopharm Latest Developments
11.4 Aruna Bio
11.4.1 Aruna Bio Company Information
11.4.2 Aruna Bio Exosome Therapeutics and Diagnostics Product Offered
11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aruna Bio Main Business Overview
11.4.5 Aruna Bio Latest Developments
11.5 Capricor Therapeutics
11.5.1 Capricor Therapeutics Company Information
11.5.2 Capricor Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Capricor Therapeutics Main Business Overview
11.5.5 Capricor Therapeutics Latest Developments
11.6 Mantra Bio
11.6.1 Mantra Bio Company Information
11.6.2 Mantra Bio Exosome Therapeutics and Diagnostics Product Offered
11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mantra Bio Main Business Overview
11.6.5 Mantra Bio Latest Developments
11.7 Adipomics
11.7.1 Adipomics Company Information
11.7.2 Adipomics Exosome Therapeutics and Diagnostics Product Offered
11.7.3 Adipomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Adipomics Main Business Overview
11.7.5 Adipomics Latest Developments
11.8 ReNeuron
11.8.1 ReNeuron Company Information
11.8.2 ReNeuron Exosome Therapeutics and Diagnostics Product Offered
11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ReNeuron Main Business Overview
11.8.5 ReNeuron Latest Developments
11.9 Aegle Therapeutics
11.9.1 Aegle Therapeutics Company Information
11.9.2 Aegle Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Aegle Therapeutics Main Business Overview
11.9.5 Aegle Therapeutics Latest Developments
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Information
11.10.2 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sarepta Therapeutics Main Business Overview
11.10.5 Sarepta Therapeutics Latest Developments
11.11 Codiak Biosciences
11.11.1 Codiak Biosciences Company Information
11.11.2 Codiak Biosciences Exosome Therapeutics and Diagnostics Product Offered
11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Codiak Biosciences Main Business Overview
11.11.5 Codiak Biosciences Latest Developments
11.12 Exosomics
11.12.1 Exosomics Company Information
11.12.2 Exosomics Exosome Therapeutics and Diagnostics Product Offered
11.12.3 Exosomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exosomics Main Business Overview
11.12.5 Exosomics Latest Developments
11.13 Innocan Pharma
11.13.1 Innocan Pharma Company Information
11.13.2 Innocan Pharma Exosome Therapeutics and Diagnostics Product Offered
11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Innocan Pharma Main Business Overview
11.13.5 Innocan Pharma Latest Developments
11.14 Aethlon Medical
11.14.1 Aethlon Medical Company Information
11.14.2 Aethlon Medical Exosome Therapeutics and Diagnostics Product Offered
11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Aethlon Medical Main Business Overview
11.14.5 Aethlon Medical Latest Developments
11.15 ExoCoBio
11.15.1 ExoCoBio Company Information
11.15.2 ExoCoBio Exosome Therapeutics and Diagnostics Product Offered
11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ExoCoBio Main Business Overview
11.15.5 ExoCoBio Latest Developments
11.16 Organicell
11.16.1 Organicell Company Information
11.16.2 Organicell Exosome Therapeutics and Diagnostics Product Offered
11.16.3 Organicell Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Organicell Main Business Overview
11.16.5 Organicell Latest Developments
11.17 Puretech
11.17.1 Puretech Company Information
11.17.2 Puretech Exosome Therapeutics and Diagnostics Product Offered
11.17.3 Puretech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Puretech Main Business Overview
11.17.5 Puretech Latest Developments
11.18 Versatope
11.18.1 Versatope Company Information
11.18.2 Versatope Exosome Therapeutics and Diagnostics Product Offered
11.18.3 Versatope Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Versatope Main Business Overview
11.18.5 Versatope Latest Developments
11.19 Vesvigen Therapeutics
11.19.1 Vesvigen Therapeutics Company Information
11.19.2 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Vesvigen Therapeutics Main Business Overview
11.19.5 Vesvigen Therapeutics Latest Developments
11.20 Exosome Plus
11.20.1 Exosome Plus Company Information
11.20.2 Exosome Plus Exosome Therapeutics and Diagnostics Product Offered
11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Exosome Plus Main Business Overview
11.20.5 Exosome Plus Latest Developments
11.21 Exosome Diagnostics
11.21.1 Exosome Diagnostics Company Information
11.21.2 Exosome Diagnostics Exosome Therapeutics and Diagnostics Product Offered
11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Exosome Diagnostics Main Business Overview
11.21.5 Exosome Diagnostics Latest Developments
11.22 ECHO Biaotech
11.22.1 ECHO Biaotech Company Information
11.22.2 ECHO Biaotech Exosome Therapeutics and Diagnostics Product Offered
11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 ECHO Biaotech Main Business Overview
11.22.5 ECHO Biaotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Exosome Therapeutics and Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Exosome Therapeutics and Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Treatment
Table 4. Major Players of Diagnosis
Table 5. Exosome Therapeutics and Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. Exosome Therapeutics and Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global Exosome Therapeutics and Diagnostics Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. Exosome Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 14. Exosome Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Table 19. Global Exosome Therapeutics and Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Country (2019-2024)
Table 33. Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Exosome Therapeutics and Diagnostics
Table 39. Key Market Challenges & Risks of Exosome Therapeutics and Diagnostics
Table 40. Key Industry Trends of Exosome Therapeutics and Diagnostics
Table 41. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Evox Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 46. Evox Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 47. Evox Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Evox Therapeutics Main Business
Table 49. Evox Therapeutics Latest Developments
Table 50. Carmine Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 51. Carmine Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 52. Carmine Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Carmine Therapeutics Main Business
Table 54. Carmine Therapeutics Latest Developments
Table 55. Exopharm Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 56. Exopharm Exosome Therapeutics and Diagnostics Product Offered
Table 57. Exopharm Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Exopharm Main Business
Table 59. Exopharm Latest Developments
Table 60. Aruna Bio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 61. Aruna Bio Exosome Therapeutics and Diagnostics Product Offered
Table 62. Aruna Bio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Aruna Bio Main Business
Table 64. Aruna Bio Latest Developments
Table 65. Capricor Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 66. Capricor Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 67. Capricor Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Capricor Therapeutics Main Business
Table 69. Capricor Therapeutics Latest Developments
Table 70. Mantra Bio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 71. Mantra Bio Exosome Therapeutics and Diagnostics Product Offered
Table 72. Mantra Bio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Mantra Bio Main Business
Table 74. Mantra Bio Latest Developments
Table 75. Adipomics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 76. Adipomics Exosome Therapeutics and Diagnostics Product Offered
Table 77. Adipomics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Adipomics Main Business
Table 79. Adipomics Latest Developments
Table 80. ReNeuron Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 81. ReNeuron Exosome Therapeutics and Diagnostics Product Offered
Table 82. ReNeuron Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. ReNeuron Main Business
Table 84. ReNeuron Latest Developments
Table 85. Aegle Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 86. Aegle Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 87. Aegle Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Aegle Therapeutics Main Business
Table 89. Aegle Therapeutics Latest Developments
Table 90. Sarepta Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 91. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 92. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Sarepta Therapeutics Main Business
Table 94. Sarepta Therapeutics Latest Developments
Table 95. Codiak Biosciences Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 96. Codiak Biosciences Exosome Therapeutics and Diagnostics Product Offered
Table 97. Codiak Biosciences Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Codiak Biosciences Main Business
Table 99. Codiak Biosciences Latest Developments
Table 100. Exosomics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 101. Exosomics Exosome Therapeutics and Diagnostics Product Offered
Table 102. Exosomics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Exosomics Main Business
Table 104. Exosomics Latest Developments
Table 105. Innocan Pharma Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 106. Innocan Pharma Exosome Therapeutics and Diagnostics Product Offered
Table 107. Innocan Pharma Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Innocan Pharma Main Business
Table 109. Innocan Pharma Latest Developments
Table 110. Aethlon Medical Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 111. Aethlon Medical Exosome Therapeutics and Diagnostics Product Offered
Table 112. Aethlon Medical Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Aethlon Medical Main Business
Table 114. Aethlon Medical Latest Developments
Table 115. ExoCoBio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 116. ExoCoBio Exosome Therapeutics and Diagnostics Product Offered
Table 117. ExoCoBio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. ExoCoBio Main Business
Table 119. ExoCoBio Latest Developments
Table 120. Organicell Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 121. Organicell Exosome Therapeutics and Diagnostics Product Offered
Table 122. Organicell Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Organicell Main Business
Table 124. Organicell Latest Developments
Table 125. Puretech Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 126. Puretech Exosome Therapeutics and Diagnostics Product Offered
Table 127. Puretech Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Puretech Main Business
Table 129. Puretech Latest Developments
Table 130. Versatope Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 131. Versatope Exosome Therapeutics and Diagnostics Product Offered
Table 132. Versatope Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Versatope Main Business
Table 134. Versatope Latest Developments
Table 135. Vesvigen Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 136. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 137. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Vesvigen Therapeutics Main Business
Table 139. Vesvigen Therapeutics Latest Developments
Table 140. Exosome Plus Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 141. Exosome Plus Exosome Therapeutics and Diagnostics Product Offered
Table 142. Exosome Plus Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Exosome Plus Main Business
Table 144. Exosome Plus Latest Developments
Table 145. Exosome Diagnostics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 146. Exosome Diagnostics Exosome Therapeutics and Diagnostics Product Offered
Table 147. Exosome Diagnostics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Exosome Diagnostics Main Business
Table 149. Exosome Diagnostics Latest Developments
Table 150. ECHO Biaotech Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 151. ECHO Biaotech Exosome Therapeutics and Diagnostics Product Offered
Table 152. ECHO Biaotech Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. ECHO Biaotech Main Business
Table 154. ECHO Biaotech Latest Developments
Table 1. Exosome Therapeutics and Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Exosome Therapeutics and Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Treatment
Table 4. Major Players of Diagnosis
Table 5. Exosome Therapeutics and Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. Exosome Therapeutics and Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global Exosome Therapeutics and Diagnostics Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. Exosome Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 14. Exosome Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Table 19. Global Exosome Therapeutics and Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Country (2019-2024)
Table 33. Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Exosome Therapeutics and Diagnostics
Table 39. Key Market Challenges & Risks of Exosome Therapeutics and Diagnostics
Table 40. Key Industry Trends of Exosome Therapeutics and Diagnostics
Table 41. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Exosome Therapeutics and Diagnostics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Evox Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 46. Evox Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 47. Evox Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Evox Therapeutics Main Business
Table 49. Evox Therapeutics Latest Developments
Table 50. Carmine Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 51. Carmine Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 52. Carmine Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Carmine Therapeutics Main Business
Table 54. Carmine Therapeutics Latest Developments
Table 55. Exopharm Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 56. Exopharm Exosome Therapeutics and Diagnostics Product Offered
Table 57. Exopharm Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Exopharm Main Business
Table 59. Exopharm Latest Developments
Table 60. Aruna Bio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 61. Aruna Bio Exosome Therapeutics and Diagnostics Product Offered
Table 62. Aruna Bio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Aruna Bio Main Business
Table 64. Aruna Bio Latest Developments
Table 65. Capricor Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 66. Capricor Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 67. Capricor Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Capricor Therapeutics Main Business
Table 69. Capricor Therapeutics Latest Developments
Table 70. Mantra Bio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 71. Mantra Bio Exosome Therapeutics and Diagnostics Product Offered
Table 72. Mantra Bio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Mantra Bio Main Business
Table 74. Mantra Bio Latest Developments
Table 75. Adipomics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 76. Adipomics Exosome Therapeutics and Diagnostics Product Offered
Table 77. Adipomics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Adipomics Main Business
Table 79. Adipomics Latest Developments
Table 80. ReNeuron Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 81. ReNeuron Exosome Therapeutics and Diagnostics Product Offered
Table 82. ReNeuron Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. ReNeuron Main Business
Table 84. ReNeuron Latest Developments
Table 85. Aegle Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 86. Aegle Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 87. Aegle Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Aegle Therapeutics Main Business
Table 89. Aegle Therapeutics Latest Developments
Table 90. Sarepta Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 91. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 92. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Sarepta Therapeutics Main Business
Table 94. Sarepta Therapeutics Latest Developments
Table 95. Codiak Biosciences Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 96. Codiak Biosciences Exosome Therapeutics and Diagnostics Product Offered
Table 97. Codiak Biosciences Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Codiak Biosciences Main Business
Table 99. Codiak Biosciences Latest Developments
Table 100. Exosomics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 101. Exosomics Exosome Therapeutics and Diagnostics Product Offered
Table 102. Exosomics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Exosomics Main Business
Table 104. Exosomics Latest Developments
Table 105. Innocan Pharma Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 106. Innocan Pharma Exosome Therapeutics and Diagnostics Product Offered
Table 107. Innocan Pharma Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Innocan Pharma Main Business
Table 109. Innocan Pharma Latest Developments
Table 110. Aethlon Medical Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 111. Aethlon Medical Exosome Therapeutics and Diagnostics Product Offered
Table 112. Aethlon Medical Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Aethlon Medical Main Business
Table 114. Aethlon Medical Latest Developments
Table 115. ExoCoBio Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 116. ExoCoBio Exosome Therapeutics and Diagnostics Product Offered
Table 117. ExoCoBio Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. ExoCoBio Main Business
Table 119. ExoCoBio Latest Developments
Table 120. Organicell Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 121. Organicell Exosome Therapeutics and Diagnostics Product Offered
Table 122. Organicell Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Organicell Main Business
Table 124. Organicell Latest Developments
Table 125. Puretech Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 126. Puretech Exosome Therapeutics and Diagnostics Product Offered
Table 127. Puretech Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Puretech Main Business
Table 129. Puretech Latest Developments
Table 130. Versatope Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 131. Versatope Exosome Therapeutics and Diagnostics Product Offered
Table 132. Versatope Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Versatope Main Business
Table 134. Versatope Latest Developments
Table 135. Vesvigen Therapeutics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 136. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product Offered
Table 137. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Vesvigen Therapeutics Main Business
Table 139. Vesvigen Therapeutics Latest Developments
Table 140. Exosome Plus Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 141. Exosome Plus Exosome Therapeutics and Diagnostics Product Offered
Table 142. Exosome Plus Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Exosome Plus Main Business
Table 144. Exosome Plus Latest Developments
Table 145. Exosome Diagnostics Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 146. Exosome Diagnostics Exosome Therapeutics and Diagnostics Product Offered
Table 147. Exosome Diagnostics Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Exosome Diagnostics Main Business
Table 149. Exosome Diagnostics Latest Developments
Table 150. ECHO Biaotech Details, Company Type, Exosome Therapeutics and Diagnostics Area Served and Its Competitors
Table 151. ECHO Biaotech Exosome Therapeutics and Diagnostics Product Offered
Table 152. ECHO Biaotech Exosome Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. ECHO Biaotech Main Business
Table 154. ECHO Biaotech Latest Developments
LIST OF FIGURES
Figure 1. Exosome Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Exosome Therapeutics and Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Exosome Therapeutics and Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Exosome Therapeutics and Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type in 2023
Figure 10. Exosome Therapeutics and Diagnostics in Cancer
Figure 11. Global Exosome Therapeutics and Diagnostics Market: Cancer (2019-2024) & ($ millions)
Figure 12. Exosome Therapeutics and Diagnostics in Neurological Diseases
Figure 13. Global Exosome Therapeutics and Diagnostics Market: Neurological Diseases (2019-2024) & ($ millions)
Figure 14. Exosome Therapeutics and Diagnostics in Others
Figure 15. Global Exosome Therapeutics and Diagnostics Market: Others (2019-2024) & ($ millions)
Figure 16. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 20. APAC Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 21. Europe Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 23. Americas Exosome Therapeutics and Diagnostics Value Market Share by Country in 2023
Figure 24. United States Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 31. China Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 54. APAC Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 55. Europe Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 57. United States Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 58. Canada Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 61. China Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 62. Japan Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 63. Korea Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 65. India Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 66. Australia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 67. Germany Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 68. France Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 69. UK Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 70. Italy Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 71. Russia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 74. Israel Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 77. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Exosome Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Exosome Therapeutics and Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Exosome Therapeutics and Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Exosome Therapeutics and Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type in 2023
Figure 10. Exosome Therapeutics and Diagnostics in Cancer
Figure 11. Global Exosome Therapeutics and Diagnostics Market: Cancer (2019-2024) & ($ millions)
Figure 12. Exosome Therapeutics and Diagnostics in Neurological Diseases
Figure 13. Global Exosome Therapeutics and Diagnostics Market: Neurological Diseases (2019-2024) & ($ millions)
Figure 14. Exosome Therapeutics and Diagnostics in Others
Figure 15. Global Exosome Therapeutics and Diagnostics Market: Others (2019-2024) & ($ millions)
Figure 16. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 20. APAC Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 21. Europe Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size 2019-2024 ($ millions)
Figure 23. Americas Exosome Therapeutics and Diagnostics Value Market Share by Country in 2023
Figure 24. United States Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 31. China Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Exosome Therapeutics and Diagnostics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 54. APAC Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 55. Europe Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 57. United States Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 58. Canada Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 61. China Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 62. Japan Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 63. Korea Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 65. India Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 66. Australia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 67. Germany Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 68. France Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 69. UK Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 70. Italy Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 71. Russia Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 74. Israel Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Exosome Therapeutics and Diagnostics Market Size 2025-2030 ($ millions)
Figure 77. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Exosome Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2025-2030)
